Protein-in-hand in 48 hours (Lunch and Learn with Nuclera)

Protein-in-hand in 48 hours: Multiplexing protein expression and purification screen on a digital microfluidic device

Understanding drug-target interactions is essential for improving leads, optimizing pharmacokinetics, and predicting in vivo efficacy.

Yet, the process of generating soluble, functional drug targets and studying their interactions with drugs can be time-consuming.

eProtein Discovery™ tackles this challenge with a multiplexed platform for protein expression and purification that allows automated screening of up to 192 expression conditions in 24 hours and consecutive protein scale up in the following 24 hours for characterization and validation. Integrating cell-free protein synthesis and digital microfluidics on smart cartridges, Nuclera’s eProtein Discovery™ enables rapid access to even challenging proteins at high quality!

Learn more on October 8th as Nuclera hosts a lunch and learn at the UMass Lowell M2D2! Sign up today!

Event Venue

M2D2 @ 110 Canal St, 4th Floor, 110 Canal Street, Lowell, United States